Cancer, chitosan nanoparticles and catalytic nucleic acids. (Q37363420)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19126291%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

review article

1 reference

title

Cancer, chitosan nanoparticles and catalytic nucleic acids (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19126291%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19126291%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19126291%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Mei Lin Tan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19126291%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Crispin R Dass

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19126291%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19126291%20AND%20SRC:MED&resulttype=core&format=json

Journal of Pharmacy and Pharmacology

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19126291%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19126291%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19126291%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

3-12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19126291%20AND%20SRC:MED&resulttype=core&format=json

The clonal evolution of tumor cell populations

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Control of tumour vascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Treatment of metastatic osteosarcoma with the somatostatin analog OncoLar: significant reduction of insulin-like growth factor-1 serum levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Midkine as a novel target for antibody therapy in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Salvaging the limb salvage: management of complications following endoprosthetic reconstruction for tumours around the knee

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

High dose ifosfamide in combination with high dose methotrexate, adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Group pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

The role of therapeutic antibodies in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Epidermal growth factor receptor targeting in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

EGFR targeting therapies: monoclonal antibodies versus tyrosine kinase inhibitors. Similarities and differences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

VEGF inhibitors in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Molecular regulation of vessel maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Clinical research. Death prompts a review of gene therapy vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Modified poly(propylene imine) dendrimers as effective transfection agents for catalytic DNA enzymes (DNAzymes).

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Antitumor effect of adenovirus-mediated p53 family gene transfer on osteosarcoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

A novel triple-regulated oncolytic adenovirus carrying p53 gene exerts potent antitumor efficacy on common human solid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Adenovirus vector induced innate immune responses: impact upon efficacy and toxicity in gene therapy and vaccine applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Nonviral gene therapy: promises and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Liposome-mediated delivery of oligodeoxynucleotides in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Oligonucleotide delivery to tumours using macromolecular carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Cyclodextrins and oligonucleotide delivery to solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

The potential risks of nanomaterials: a review carried out for ECETOC

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

21 January 2018

Liposomal nanomedicines

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Dextran-coated gold nanoparticles for the assessment of antimicrobial susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Liposomes as carriers of antitumor agents: toward a clinical reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Liposomal encapsulated anti-cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Dendrimers as drug delivery vehicles: non-covalent interactions of bioactive compounds with dendrimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Dendrimer biocompatibility and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Highly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Tumour cell delivery of antisense oligonuclceotides by human serum albumin nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Gold nanoparticles as carriers for efficient transmucosal insulin delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Chitosan--as a biomaterial

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Design of nanoparticles composed of graft copolymers for oral peptide delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

In vitro degradation of chitosan by a commercial enzyme preparation: effect of molecular weight and degree of deacetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Chitosan microparticles encapsulating PEDF plasmid demonstrate efficacy in an orthotopic metastatic model of osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Chitosan induces apoptosis via caspase-3 activation in bladder tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Chitosan-based gastrointestinal delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Preparation and characterization of cationic PLGA nanospheres as DNA carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

DNA-polycation nanospheres as non-viral gene delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Chitosan and lactic acid-grafted chitosan nanoparticles as carriers for prolonged drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

A general purpose RNA-cleaving DNA enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Inhibition of bcr-abl oncogene expression by novel deoxyribozymes (DNAzymes).

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

DNAzymes to beta 1 and beta 3 mRNA down-regulate expression of the targeted integrins and inhibit endothelial cell capillary tube formation in fibrin and matrigel

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Gene silencing nucleic acids designed by scanning arrays: anti-EGFR activity of siRNA, ribozyme and DNA enzymes targeting a single hybridization-accessible region using the same delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Targeting PML/RARalpha transcript with DNAzymes results in reduction of proliferation and induction of apoptosis in APL cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Inhibition of urokinase receptor gene expression and cell invasion by anti-uPAR DNAzymes in osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

DNAzyme technology and cancer therapy: cleave and let die.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Inhibition of human breast carcinoma proliferation, migration, chemoinvasion and solid tumour growth by DNAzymes targeting the zinc finger transcription factor EGR-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Effect of deoxyribozymes targeting c-Jun on solid tumor growth and angiogenesis in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

RNA cleaving '10-23' DNAzymes with enhanced stability and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Nucleic-acid therapeutics: basic principles and recent applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

c-Jun knockdown sensitizes osteosarcoma to doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Cleavage of the siRNA passenger strand during RISC assembly in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

In vivo imaging of siRNA delivery and silencing in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Mammalian RNAi: a practical guide

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Gene silencing by small regulatory RNAs in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Anti-tumor effects of anti-VEGF siRNA encapsulated with PLGA microspheres in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Development and characterisation of chitosan nanoparticles for siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Hollow chitosan-alginate multilayer microcapsules as drug delivery vehicle: doxorubicin loading and in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002

Doxorubicin in sterically stabilized liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.61.01.0002